BR0115423A - Uso de um inibidor de aromatase, uso de exemestano e triptorelina ou um sal destes farmaceuticamente aceitável, e, produto - Google Patents

Uso de um inibidor de aromatase, uso de exemestano e triptorelina ou um sal destes farmaceuticamente aceitável, e, produto

Info

Publication number: BR0115423A
Authority: BR; Brazil
Prior art keywords: aromatase inhibitor; triptorelin; pharmaceutically acceptable; acceptable salt; exemestane
Prior art date: 2000-11-16

Application number

BR0115423-0A

Other languages

English (en)

Portuguese (pt)

Inventor

Dinesh Purandare

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-16

Filing date

2001-11-06

Publication date

2005-12-13

2001-11-06 Application filed by Upjohn Co filed Critical Upjohn Co

2005-12-13 Publication of BR0115423A publication Critical patent/BR0115423A/pt

Links

229940122815 Aromatase inhibitor Drugs 0.000 title abstract 4
239000003886 aromatase inhibitor Substances 0.000 title abstract 4
108010050144 Triptorelin Pamoate Proteins 0.000 title abstract 3
150000003839 salts Chemical class 0.000 title abstract 3
VXKHXGOKWPXYNA-PGBVPBMZSA-N triptorelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 VXKHXGOKWPXYNA-PGBVPBMZSA-N 0.000 title abstract 3
229960004824 triptorelin Drugs 0.000 title abstract 3
BFYIZQONLCFLEV-DAELLWKTSA-N Aromasine Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC(=C)C2=C1 BFYIZQONLCFLEV-DAELLWKTSA-N 0.000 title abstract 2
229960000255 exemestane Drugs 0.000 title abstract 2
241000124008 Mammalia Species 0.000 abstract 2
238000004519 manufacturing process Methods 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
230000001419 dependent effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
210000001672 ovary Anatomy 0.000 abstract 1
238000012360 testing method Methods 0.000 abstract 1
210000001550 testis Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BR0115423-0A 2000-11-16 2001-11-06 Uso de um inibidor de aromatase, uso de exemestano e triptorelina ou um sal destes farmaceuticamente aceitável, e, produto BR0115423A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US71460500A	2000-11-16	2000-11-16
PCT/US2001/043847 WO2002039995A2 (en)	2000-11-16	2001-11-06	Combination therapy for estrogen-dependent disorders

Publications (1)

Publication Number	Publication Date
BR0115423A true BR0115423A (pt)	2005-12-13

Family

ID=24870727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR0115423-0A BR0115423A (pt)	2000-11-16	2001-11-06	Uso de um inibidor de aromatase, uso de exemestano e triptorelina ou um sal destes farmaceuticamente aceitável, e, produto

Country Status (16)

Country	Link
EP (1)	EP1341549A2 (cs)
JP (1)	JP2004536022A (cs)
KR (1)	KR20030051828A (cs)
CN (1)	CN1498112A (cs)
AU (1)	AU2002230464A1 (cs)
BR (1)	BR0115423A (cs)
CA (1)	CA2428249A1 (cs)
CZ (1)	CZ20031349A3 (cs)
EA (1)	EA200300572A1 (cs)
IL (1)	IL155817A0 (cs)
MX (1)	MXPA03004195A (cs)
NO (1)	NO20032206L (cs)
NZ (1)	NZ525720A (cs)
PL (1)	PL365904A1 (cs)
WO (1)	WO2002039995A2 (cs)
ZA (1)	ZA200303669B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL153218A0 (en)	2000-06-02	2003-07-06	Univ Texas	Ethylenedicysteine (ec) -drug conjugates
US9050378B2 (en)	2003-12-10	2015-06-09	Board Of Regents, The University Of Texas System	N2S2 chelate-targeting ligand conjugates
GB0506759D0 (en) *	2005-04-02	2005-05-11	Medical Res Council	Combination treatment methods
EP1891964A1 (en) *	2006-08-08	2008-02-27	AEterna Zentaris GmbH	Application of initial doses of LHRH analogues and maintenance doses of LHRH antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits
US10925977B2 (en)	2006-10-05	2021-02-23	Ceil>Point, LLC	Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
US20080261933A1 (en) *	2007-04-23	2008-10-23	Jens Hoffmann	Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
CN101775054B (zh) *	2010-02-05	2012-12-26	常州佳尔科药业集团有限公司	4-羟基-4-烯-3-酮甾族化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9911582D0 (en) *	1999-05-18	1999-07-21	Pharmacia & Upjohn Spa	Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound
GB9930839D0 (en) *	1999-12-30	2000-02-16	Pharmacia & Upjohn Spa	Process for treating gynecomastia

2001
- 2001-11-06 KR KR10-2003-7006608A patent/KR20030051828A/ko not_active Withdrawn
- 2001-11-06 EA EA200300572A patent/EA200300572A1/ru unknown
- 2001-11-06 CZ CZ20031349A patent/CZ20031349A3/cs unknown
- 2001-11-06 AU AU2002230464A patent/AU2002230464A1/en not_active Abandoned
- 2001-11-06 BR BR0115423-0A patent/BR0115423A/pt not_active IP Right Cessation
- 2001-11-06 NZ NZ525720A patent/NZ525720A/en unknown
- 2001-11-06 PL PL01365904A patent/PL365904A1/xx not_active Application Discontinuation
- 2001-11-06 MX MXPA03004195A patent/MXPA03004195A/es unknown
- 2001-11-06 IL IL15581701A patent/IL155817A0/xx unknown
- 2001-11-06 EP EP01990699A patent/EP1341549A2/en not_active Withdrawn
- 2001-11-06 CN CNA018189385A patent/CN1498112A/zh active Pending
- 2001-11-06 JP JP2002542370A patent/JP2004536022A/ja active Pending
- 2001-11-06 WO PCT/US2001/043847 patent/WO2002039995A2/en not_active Ceased
- 2001-11-06 CA CA002428249A patent/CA2428249A1/en not_active Abandoned
2003
- 2003-05-13 ZA ZA200303669A patent/ZA200303669B/en unknown
- 2003-05-15 NO NO20032206A patent/NO20032206L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ20031349A3 (cs)	2004-05-12
KR20030051828A (ko)	2003-06-25
NO20032206L (no)	2003-07-15
JP2004536022A (ja)	2004-12-02
NO20032206D0 (no)	2003-05-15
NZ525720A (en)	2006-12-22
CN1498112A (zh)	2004-05-19
EP1341549A2 (en)	2003-09-10
AU2002230464A1 (en)	2002-05-27
CA2428249A1 (en)	2002-05-23
EA200300572A1 (ru)	2004-06-24
PL365904A1 (en)	2005-01-10
IL155817A0 (en)	2003-12-23
MXPA03004195A (es)	2003-09-22
WO2002039995A9 (en)	2003-02-06
WO2002039995A2 (en)	2002-05-23
ZA200303669B (en)	2004-05-13
WO2002039995A3 (en)	2003-05-01

Similar Documents

Publication	Publication Date	Title
UA41879C2 (uk)	2001-10-15	Засіб для лікування мотонейронових захворювань
ATE215081T1 (de)	2002-04-15	Gonadotropin releasing hormon- antagonisten
CY1110085T1 (el)	2015-01-14	Μεθοδος θεραπειας της δυσλειτουργιας στυσης και αυξησης της λιμπιντο στους ανδρες
BR0115109A (pt)	2005-10-18	Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
PT1068870E (pt)	2006-10-31	Agentes antitumorais
AR002007A1 (es)	1998-01-07	UNA COMPOSICION TERAPEUTICA DE APLICACION TOPICA QUE CONTIENE UN ANTAGONISTA DE SUSTANCIA P Y UTILIZACION DE DICHO ANTAGONISTA PARA LAPREPARACIóN DE DICHA COMPOSICION PARA DISMINUIR Y/O ELIMINAR UN EFECTO SECUNDARIO IRRITANTE DE UN PRODUCTO CONTENIDO EN LA MISMA.
ATE304840T1 (de)	2005-10-15	Hautpflegezusammensetzung
GB9807639D0 (en)	1998-06-10	Anti-inflammatory agents
WO2001078701A3 (en)	2002-07-25	Method and compositions for preventing hormone induced adverse effects
BR0113649A (pt)	2004-07-20	Processo para aumentar a testosterona e as relacionadas concentrações de esteróide em mulheres
CL2010000018A1 (es)	2010-06-04	Fragmentos de peptido amiloide beta(ab) ab 1-7 y ab 3-7 ligados a un peptido portador, composicion farmaceutica que lo comprende y su uso para tratar la enfermedad de alzheimer
MX9804850A (es)	1998-09-30	Antagonistas de hormona liberadora de gonadotropina.
BR0308429A (pt)	2005-01-11	Aroilpiridinonas monocìclicas como agentes antiinflamatórios
AU7400101A (en)	2001-11-20	Ortho-substituted anthranilic acid amides and their use as medicaments
BR0113625A (pt)	2003-07-22	Exemestano como agente de quimioprevenção
BR9612207A (pt)	1999-07-13	Processo e kit para contracepções em mamíferos fêmeas consistindo de uma combinação de gestageno e estrogênio
BR0115423A (pt)	2005-12-13	Uso de um inibidor de aromatase, uso de exemestano e triptorelina ou um sal destes farmaceuticamente aceitável, e, produto
DK1280558T3 (da)	2005-12-27	Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
BR0113148A (pt)	2003-07-08	Composições de 2-piridinamina e métodos relacionados
BR0113165A (pt)	2003-07-15	Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
ES2136581A1 (es)	1999-11-16	Uso de derivados del acido-2-hidroxi-4-trifluorometilbenzoico para la preparacion de medicamentos utiles para inhibir el factor de transcripcion nuclear nf-kb.
ATE353224T1 (de)	2007-02-15	Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
WO2001041747A3 (de)	2002-02-07	Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
GT199900062A (es)	2000-10-20	Preparados efervescentes.
DE59002738D1 (de)	1993-10-21	Kombinationspräparate enthaltend Chloramphenicol, Gentamicin und Nystatin als aktive Wirkstoffe zur topischen Behandlung entzündlicher Hauterkrankungen.

Legal Events

Date	Code	Title	Description
2009-09-29	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A E 8A ANUIDADES.
2010-11-16	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009.